Literature DB >> 33483597

Real-time lipid patterns to classify viable and necrotic liver tumors.

Pierre-Maxence Vaysse1,2,3, Heike I Grabsch4,5, Mari F C M van den Hout4, Marc H A Bemelmans2,6, Ron M A Heeren1, Steven W M Olde Damink2,7,8, Tiffany Porta Siegel9.   

Abstract

Real-time tissue classifiers based on molecular patterns are emerging tools for fast tumor diagnosis. Here, we used rapid evaporative ionization mass spectrometry (REIMS) and multivariate statistical analysis (principal component analysis-linear discriminant analysis) to classify tissues with subsequent comparison to gold standard histopathology. We explored whether REIMS lipid patterns can identify human liver tumors and improve the rapid characterization of their underlying metabolic features. REIMS-based classification of liver parenchyma (LP), hepatocellular carcinoma (HCC), and metastatic adenocarcinoma (MAC) reached an accuracy of 98.3%. Lipid patterns of LP were more similar to those of HCC than to those of MAC and allowed clear distinction between primary and metastatic liver tumors. HCC lipid patterns were more heterogeneous than those of MAC, which is consistent with the variation seen in the histopathological phenotype. A common ceramide pattern discriminated necrotic from viable tumor in MAC with 92.9% accuracy and in other human tumors. Targeted analysis of ceramide and related sphingolipid mass features in necrotic tissues may provide a new classification of tumor cell death based on metabolic shifts. Real-time lipid patterns may have a role in future clinical decision-making in cancer precision medicine.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33483597     DOI: 10.1038/s41374-020-00526-w

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  47 in total

Review 1.  Metabolic profiles of cancer cells.

Authors:  Julian L Griffin; John P Shockcor
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

Review 2.  Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.

Authors:  Li Zhou; Kui Wang; Qifu Li; Edouard C Nice; Haiyuan Zhang; Canhua Huang
Journal:  Expert Rev Proteomics       Date:  2016-03-16       Impact factor: 3.940

Review 3.  Sphingolipid metabolism in cancer signalling and therapy.

Authors:  Besim Ogretmen
Journal:  Nat Rev Cancer       Date:  2017-11-17       Impact factor: 60.716

4.  The influence of temperature changes on the PO2 of normal anaerobic blood samples.

Authors:  G J van Stekelenburg
Journal:  Respir Physiol       Date:  1970-01

Review 5.  Sphingolipids and their metabolism in physiology and disease.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-22       Impact factor: 94.444

Review 6.  Applications of Metabolomics in Cancer Studies.

Authors:  Emily Grace Armitage; Michal Ciborowski
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 7.  Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes.

Authors:  Jasmine A McQuerry; Jeffrey T Chang; David D L Bowtell; Adam Cohen; Andrea H Bild
Journal:  J Mol Med (Berl)       Date:  2017-09-04       Impact factor: 4.599

Review 8.  Precision medicine for cancer with next-generation functional diagnostics.

Authors:  Adam A Friedman; Anthony Letai; David E Fisher; Keith T Flaherty
Journal:  Nat Rev Cancer       Date:  2015-11-05       Impact factor: 60.716

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 10.  Rise of Deep Learning for Genomic, Proteomic, and Metabolomic Data Integration in Precision Medicine.

Authors:  Dmitry Grapov; Johannes Fahrmann; Kwanjeera Wanichthanarak; Sakda Khoomrung
Journal:  OMICS       Date:  2018-08-20
View more
  3 in total

1.  Towards real-time intraoperative tissue interrogation for REIMS-guided glioma surgery.

Authors:  Laura Van Hese; Steven De Vleeschouwer; Tom Theys; Emma Larivière; Lien Solie; Raf Sciot; Tiffany Porta Siegel; Steffen Rex; Ron M A Heeren; Eva Cuypers
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2022-04-29

2.  Fast detection, a precise and sensitive diagnostic agent for breast cancer.

Authors:  Qiong Wu; Chanling Yuan; Ningzhi Liu; Jing Shu; Jiacheng Wang; Jiayi Qian; Liang Zeng; Hao Zhang; Xicheng Wang; Wenjie Mei
Journal:  J Exp Clin Cancer Res       Date:  2022-06-13

3.  Evaluation of the Sensitivity of Metabolic Profiling by Rapid Evaporative Ionization Mass Spectrometry: Toward More Radical Oral Cavity Cancer Resections.

Authors:  Pierre-Maxence Vaysse; Imke Demers; Mari F C M van den Hout; Wouter van de Worp; Ian G M Anthony; Laura W J Baijens; Bing I Tan; Martin Lacko; Lauretta A A Vaassen; Auke van Mierlo; Ramon C J Langen; Ernst-Jan M Speel; Ron M A Heeren; Tiffany Porta Siegel; Bernd Kremer
Journal:  Anal Chem       Date:  2022-05-03       Impact factor: 8.008

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.